Scientific Review of the Proarrhythmic Risks of Oligonucleotide Therapeutics: Are Dedicated ICH S7B/E14 Studies Needed for Low‐Risk Modalities?

Qu, Yusheng ; Henderson, Kim A. ; Harper, Tod A. ; Vargas, Hugo M.

Clinical pharmacology and therapeutics, 2024-07, Vol.116 (1), p.96-105 [Periódico revisado por pares]

United States

Texto completo disponível